Long term effectiveness of live herpes zoster vaccine
- PMID: 37940164
- DOI: 10.1136/bmj.p2497
Long term effectiveness of live herpes zoster vaccine
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: CRS reports research grants paid to his institution from UK Research and Innovation, the UK Medical Research Council, the UK National Institute for Health Research, the New Zealand Ministry of Business, Innovation and Employment, the Health Research Council of New Zealand, the New Zealand Ministry of Health, and the UK Chief Scientist Office, all outside of the submitted work. CRS also reports a leadership or fiduciary role in other boards, societies, committees, or advocacy groups, paid or unpaid, with the New Zealand Government Chief Data Steward’s Data Ethics Advisory Group. JM reports none. Further details of The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.
Comment on
-
Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records.BMJ. 2023 Nov 8;383:e076321. doi: 10.1136/bmj-2023-076321. BMJ. 2023. PMID: 37940142 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical